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Does Sex Matter?*Alexandra J. Lansky, MD, Cody PietrasI n this issue of JACC: Cardiovascular Inter-ventions, Kobayashi et al. (1) investigate sexdifferences in invasive measures of microvas-
cular function and challenge the widely held view
that microvascular dysfunction is the primary cause
of the high prevalence of angina in the absence
of obstructive coronary artery disease (CAD) in
women.SEE PAGE 1433HISTORICAL PERSPECTIVE
An estimated 10.2 million Americans have angina (2).
Women in particular have a consistent excess of
angina in the United States and worldwide, seemingly
indicative of an inherent sex-based disparity in the
biological basis for chest pain (3). Among symptom-
atic patients without previous known CAD referred
for cardiac catheterization, more than 60% are found
to have nonobstructive CAD (<50% diameter stenosis
[DS]), and 39% have “normal” coronary arteries
(<20% DS); women account for 55% of patients
without obstructive CAD and only 34% with signiﬁ-
cant stenosis (4). Women consistently demonstrate
less obstructive coronary artery disease compared
with men, irrespective of presentation with stable or
unstable coronary syndromes (5,6).
Among outpatients with known CAD, anginal
symptoms predict mortality: the mortality rate in-
creases by 27%, 61%, and 250% for mild, moderate,
and severely limiting angina, respectively (7).
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angina itself conferred a worse prognosis: the 5-year
annualized cardiovascular event rate (death, myo-
cardial infarction, stroke, and hospitalization for
heart failure) was 16% for symptomatic women with
nonobstructive CAD, 8% for symptomatic women
with normal coronaries, and 2.4% for asymptomatic
women without CAD (8–10).
Further investigation by the WISE into the mech-
anisms of angina in women with nonobstructive
CAD (N ¼ 159) revealed that almost one-half of
women had abnormal coronary ﬂow reserve (CFR),
indicating that microvascular dysfunction may be a
root cause of angina (11). Furthermore, both
endothelium-dependent (12) and -independent (13)
abnormal CFR was associated with an increased
incidence of adverse cardiac events.
Another WISE substudy demonstrated that at
least 20% of women with angina and nonobstructive
CAD had evidence of myocardial ischemia by nu-
clear magnetic resonance spectroscopy (MRS), again
postulated to be due to atherosclerosis-related mic-
rovascular dysfunction. Women with abnormal MRS
had a higher 3-year composite event rate, driven
primarily by rehospitalization for unstable angina,
which was associated with repeat catheterization and
higher health care costs (9). Similar ﬁndings were
noted in a smaller series of women with angina and
“normal” coronaries, 20% of whom displayed myo-
cardial ischemia on MRS (14). Although microvascular
or endothelial dysfunction is thought to be the most
plausible mechanism, other potential physiological
mechanisms include coronary vasospasm and in-
creased left ventricular diastolic pressure due to
impaired myocardial relaxation. The main takeaway
from the WISE studies has been that microvascular
dysfunction is central to the pathobiology of non-
obstructive ischemic heart disease in women and
accounts for their symptoms and prognosis.
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1443CONTRIBUTION OF THE CURRENT STUDY
The current study by Kobayashi et al. (1) clariﬁes 2
important points in our understanding of women
with angina and nonobstructive CAD. First, micro-
vascular function measured by the index of micro-
vascular resistance (IMR) was similar between the
sexes. IMR is a direct measure of microvascular
function that eliminates the variability of resting
vascular tone by incorporating only hyperemic pa-
rameters, making it more reproducible than CFR (15).
Second, CFR was lower in women due to a shorter
resting mean transit time. CFR, deﬁned as hyperemic
coronary ﬂow divided by resting coronary ﬂow, is
subject to substantial variation due to resting hemo-
dynamic changes (e.g., blood pressure, heart rate,
myocardial contractility) and epicardial artery pa-
thology. In this study, both hypertension and small
coronary vessel size predicted reduced resting transit
time and therefore contributed to abnormal CFR.
These important observations suggest that women
have increased resting coronary ﬂow—possibly re-
lated to a higher prevalence of hypertension and
possibly to smaller vessels—rather than more ab-
normal microvascular function. These ﬁndings shed
important new light on the pathobiology of ischemic
heart disease in women in whom vascular dysfunc-
tion was thought to be central (16). Based on the
current study—the ﬁrst to include men for direct
comparison—microvascular function appears to be
similar between the sexes.
This study also provides insight into nonath-
erosclerotic contributors to the adverse prognosis
associated with the abnormal CFR observed in the
WISE study. Reduced resting coronary ﬂow was as-
sociated with hypertension and small vessel caliber,
both of which are more common in women. In the
setting of smaller vessels, hypertension (particularly
prevalent in elderly women) and diastolic dysfunction
may precipitate ischemia and anginal symptoms,
leading to the observed prognosis. The complex
interplay of nonobstructive atherosclerosis, hyper-
tension, and diastolic dysfunction, compounded by
other risk factors common to women including insulin
resistance, metabolic syndrome, and diabetes, likely
contributes to the symptoms and functional limita-
tions observed in women.
OTHER CLINICAL CONSIDERATIONS
Most studies evaluating the prognosis of angina and
measures of CFR were conducted exclusively in
women and included patients with angiographically
deﬁned nonobstructive disease (<50% DS) as well asnormal coronary arteries (<20% DS). Intravascular
ultrasound (IVUS) studies have illuminated the
enormous burden and diffuse nature of atheroscle-
rosis in patients with nonobstructive CAD: in a WISE
substudy, 80% of women with nonobstructive CAD
had a mean atheroma volume of 30  8% involving
more than 40% of the interrogated vessel length, and
73% had evidence of positive remodeling, indicating
that angiography signiﬁcantly underestimates the
extent of disease (17). The PROSPECT (Providing
Regional Observations to Study Predictors of Events
in the Coronary Tree) trial demonstrated the sub-
stantial incremental impact of even mild angio-
graphic lesions (2.6% to 34% DS) on IVUS plaque
burden (46% to 51%) and subsequent cardiovascular
events (ranging from 0.3% to 5.1%), in addition to
residual angina (18). Furthermore, women may be
more vulnerable to intermediate lesions with thin-
cap ﬁbroatheroma, as detected by virtual histology
IVUS (19). These observations alone may be sufﬁcient
to explain the increased incidence of cardiovascular
events in women with angina despite the absence of
obstructive CAD, without invoking fundamental sex-
based biological differences in the pathophysiology
of angina.SUMMARY
As Kobayashi et al. (1) point out in their elegant
study, the emphasis on microvascular dysfunction as
the primary cause of the sex differences in anginal
symptoms in the absence of obstructive CAD may
have been misguided. Based on these new data, it
appears unlikely that the fundamental pathophysi-
ology of ischemic heart disease is different between
the sexes; rather, sex-based disparities in the preva-
lence and combination of known risk factors result in
different manifestations of disease in women
compared with men. The degree to which microvas-
cular dysfunction is a contributor to sex differences
remains to be determined in larger comparative
studies that include both men and women. Future
efforts should be directed at elucidating the relative
contributions of known risk factors including dis-
ease severity and burden to abnormal coronary
ﬂow to better tailor effective therapies to each
patient.
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